Rhenman & Partners Asset Management AB Has $2.04 Million Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Rhenman & Partners Asset Management AB decreased its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Pliant Therapeutics were worth $2,042,000 […]

Related Keywords

United States ,Canada , ,Exchange Commission ,Needham Company ,Silverarc Capital Management ,Vanguard Group Inc ,Pliant Therapeutics Inc ,Royal Bank ,Barclays Plc ,Holdings Channel ,Citigroup ,Nasdaq ,Pliant Therapeutics Company Profile ,Franklin Resources Inc ,Partners Asset Management ,Pliant Therapeutics ,Free Report ,Capital Management ,Franklin Resources ,Get Free Report ,Visit Holdingschannel ,Pliant Therapeutics Daily ,